Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Lienhardt

Showing results (41-50 of 116) with videos related to

Pageof 12
Sort By:
BMC Pharmacology & Toxicology|November 20, 2014
Randomized pharmacokinetic evaluation of different rifabutin doses in African HIV- infected tuberculosis patients on lopinavir/ritonavir-based antiretroviral therapySuhashni Naiker, Cathy Connolly, Lubbe Wiesner, et al.
The Lancet. Global Health|May 18, 2024
Economic implications of novel regimens for tuberculosis treatment in three high-burden countries: a modelling analysisTheresa S Ryckman, Samuel G Schumacher, Christian Lienhardt, et al.
American Journal of Respiratory and Critical Care Medicine|May 30, 2003
Risk factors for tuberculosis infection in sub-Saharan Africa: a contact study in The GambiaChristian Lienhardt, Katherine Fielding, Jackson Sillah, et al.
BMJ Global Health|April 3, 2018
Priorities for global political momentum to end TB: a critical point in timeTereza Kasaeva, Annabel Baddeley, Katherine Floyd, et al.
Lancet (London, England)|April 20, 2020
French research strategy to tackle antimicrobial resistanceEvelyne Jouvin-Marche, Guia Carrara, Céline Pulcini, et al.
BMC Medicine|May 17, 2022
Prioritising attributes for tuberculosis preventive treatment regimens: a modelling analysisJuan F Vesga, Christian Lienhardt, Placide Nsengiyumva, et al.
Trials|February 17, 2026
Evaluation of a combined tuberculosis case-finding, treatment and prevention strategy in Thailand: protocol for a pragmatic phase IV stepped-wedge cluster-randomised trial, the CaPThai studyTamara Tovar Sanchez, Jintana Ngamvithayapong-Yanai, Daniel Grint, et al.
The European Respiratory Journal|January 27, 2017
Target regimen profiles for treatment of tuberculosis: a WHO documentChristian Lienhardt, Payam Nahid, Michael L Rich, et al.
Antimicrobial Agents and Chemotherapy|April 26, 2017
Effects on the QT Interval of a Gatifloxacin-Containing Regimen versus Standard Treatment of Pulmonary TuberculosisPiero L Olliaro, Corinne Merle, Thuli Mthiyane, et al.
Plos Medicine|June 13, 2022
Scaling up target regimens for tuberculosis preventive treatment in Brazil and South Africa: An analysis of costs and cost-effectivenessNtwali Placide Nsengiyumva, Jonathon R Campbell, Olivia Oxlade, et al.
Pageof 12

Showing results (41-50 of 116) with videos related to

Sort By:
Pageof 12
BMC Pharmacology & Toxicology|November 20, 2014
Randomized pharmacokinetic evaluation of different rifabutin doses in African HIV- infected tuberculosis patients on lopinavir/ritonavir-based antiretroviral therapySuhashni Naiker, Cathy Connolly, Lubbe Wiesner, et al.
The Lancet. Global Health|May 18, 2024
Economic implications of novel regimens for tuberculosis treatment in three high-burden countries: a modelling analysisTheresa S Ryckman, Samuel G Schumacher, Christian Lienhardt, et al.
American Journal of Respiratory and Critical Care Medicine|May 30, 2003
Risk factors for tuberculosis infection in sub-Saharan Africa: a contact study in The GambiaChristian Lienhardt, Katherine Fielding, Jackson Sillah, et al.
BMJ Global Health|April 3, 2018
Priorities for global political momentum to end TB: a critical point in timeTereza Kasaeva, Annabel Baddeley, Katherine Floyd, et al.
Lancet (London, England)|April 20, 2020
French research strategy to tackle antimicrobial resistanceEvelyne Jouvin-Marche, Guia Carrara, Céline Pulcini, et al.
BMC Medicine|May 17, 2022
Prioritising attributes for tuberculosis preventive treatment regimens: a modelling analysisJuan F Vesga, Christian Lienhardt, Placide Nsengiyumva, et al.
Trials|February 17, 2026
Evaluation of a combined tuberculosis case-finding, treatment and prevention strategy in Thailand: protocol for a pragmatic phase IV stepped-wedge cluster-randomised trial, the CaPThai studyTamara Tovar Sanchez, Jintana Ngamvithayapong-Yanai, Daniel Grint, et al.
The European Respiratory Journal|January 27, 2017
Target regimen profiles for treatment of tuberculosis: a WHO documentChristian Lienhardt, Payam Nahid, Michael L Rich, et al.
Antimicrobial Agents and Chemotherapy|April 26, 2017
Effects on the QT Interval of a Gatifloxacin-Containing Regimen versus Standard Treatment of Pulmonary TuberculosisPiero L Olliaro, Corinne Merle, Thuli Mthiyane, et al.
Plos Medicine|June 13, 2022
Scaling up target regimens for tuberculosis preventive treatment in Brazil and South Africa: An analysis of costs and cost-effectivenessNtwali Placide Nsengiyumva, Jonathon R Campbell, Olivia Oxlade, et al.
Pageof 12